probucol has been researched along with Nevoxanthoendothelioma in 1 studies
Probucol: A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
probucol : A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saito, M | 1 |
| Tada, Y | 1 |
| Harada-Shiba, M | 1 |
| Yamamoto, A | 1 |
| Kusakabe, N | 1 |
| Yokogawa, M | 1 |
| Kodama, H | 1 |
| Asada, H | 1 |
| Miyagawa, S | 1 |
1 other study available for probucol and Nevoxanthoendothelioma
| Article | Year |
|---|---|
Homozygous familial hypercholesterolaemia: development of xanthogranuloma in a boy at puberty under long-term low-density lipoprotein apheresis and drug therapy.
Topics: Adolescent; Anticholesteremic Agents; Blood Component Removal; Humans; Hyperlipoproteinemia Type II; | 2003 |